{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:29:14Z","timestamp":1791329354000,"version":"4.3.1"},"reference-count":52,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Solar urticaria is a rare and disabling photodermatosis. Due to its low prevalence, most available data regarding treatment are derived from observational studies and case series, and a systematic evaluation of treatment efficacy is lacking. This systematic review and meta-analysis aims to assess therapeutic outcomes across treatment modalities in order to guide clinical care. Methods: We conducted a systematic literature search across PubMed, ScienceDirect, the Cochrane Library, and ClinicalTrials.gov. Studies reporting treatment outcomes in patients with solar urticaria were included. Pooled response rates were calculated for each treatment modality. Results: Out of 508 studies initially identified, 38 met the inclusion criteria. Antihistamines were evaluated in 21 studies (376 patients), with a pooled response rate (partial or complete) of 83.0% (95% CI, 70.4\u201391.1%) and a complete response rate of 7.7% (95% CI, 1.7\u201328.3%). Phototherapy was assessed in 11 studies (145 patients), showing a similar overall response (89.8%; 95% CI, 77.9\u201395.3%) but a higher complete response rate (39.8%; 95% CI, 18.3\u201366.1%). Omalizumab, evaluated in nine studies (76 patients), demonstrated the highest efficacy, with 93.2% (95% CI, 73.8\u201398.5%) achieving response and 68.4% (95% CI, 48.5\u201383.2%) complete remission. Limited data on IVIG, cyclosporine, and plasmapheresis suggested partial efficacy in selected refractory cases. Conclusions: This meta-analysis may support clinical decision-making by clinicians. A stepwise approach is suggested: high-dose H1 antihistamines as first-line therapy, phototherapy as an alternative option in patients with access to treatment centers, and omalizumab for those with insufficient response. In refractory cases, additional options might be considered.<\/jats:p>","DOI":"10.3390\/jcm14165736","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:53:27Z","timestamp":1755100407000},"page":"5736","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of Therapies for Solar Urticaria: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"14","author":[{"given":"Maya","family":"Engler Markowitz","sequence":"first","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Petach Tikva 49100, Israel"},{"name":"Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2481-4714","authenticated-orcid":false,"given":"Yehonatan","family":"Noyman","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Petach Tikva 49100, Israel"},{"name":"Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Khanimov","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Petach Tikva 49100, Israel"},{"name":"Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8089-1592","authenticated-orcid":false,"given":"Itay","family":"Zahavi","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7488-035X","authenticated-orcid":false,"given":"Batya","family":"Davidovici","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Petach Tikva 49100, Israel"},{"name":"Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2964-7417","authenticated-orcid":false,"given":"Riad","family":"Kassem","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv 69978, Israel"},{"name":"Department of Dermatology, Sheba Medical Center, Tel Hashomer, Ramt Gan 52621, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7158-2085","authenticated-orcid":false,"given":"Daniel","family":"Mimouni","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Petach Tikva 49100, Israel"},{"name":"Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assi","family":"Levi","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center, Petach Tikva 49100, Israel"},{"name":"Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jaad.2008.08.020","article-title":"Solar urticaria","volume":"59","author":"Botto","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/phpp.12385","article-title":"Solar urticaria in 145 patients: Assessment of action spectra and impact on quality of life in adults and children","volume":"34","author":"Haylett","year":"2018","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and 7chronic urticaria: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1684\/ejd.2013.1933","article-title":"Solar urticaria: A time-extended retrospective series of 61 patients and review of literature","volume":"23","author":"Debu","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/phpp.12186","article-title":"Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity","volume":"31","author":"Levi","year":"2015","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1067\/mjd.2000.104517","article-title":"UVA rush hardening for the treatment of solar urticaria","volume":"42","author":"Beissert","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2133.1987.tb05875.x","article-title":"UVB phototherapy and photochemotherapy (PUVA) in the treatment of polymorphic light eruption and solar urticaria","volume":"116","author":"Addo","year":"1987","journal-title":"Br. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaip.2018.02.032","article-title":"Omalizumab for the Treatment of Solar Urticaria: Case Series and Systematic Review of the Literature","volume":"6","author":"Snast","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2350229","DOI":"10.1080\/09546634.2024.2350229","article-title":"Successful serial plasmapheresis for solar urticaria, a case report and literature review","volume":"35","author":"Boontaveeyuwat","year":"2024","journal-title":"J. Dermatolog. Treat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0781.1997.tb00109.x","article-title":"Cyclosporin A therapy for severe solar urticaria","volume":"13","author":"Ros","year":"1997","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000193998","article-title":"Solar urticaria successfully treated with intravenous immunoglobulins","volume":"218","author":"Maksimovic","year":"2009","journal-title":"Dermatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_13","first-page":"2127","article-title":"Methodological quality of case series studies: An introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.11124\/JBIES-23-00268","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies","volume":"22","author":"Barker","year":"2024","journal-title":"JBI Evid. Synth."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.11124\/JBIES-22-00430","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid. Synth."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/ddg.14309","article-title":"Solar urticaria: Clinic, diagnostic, course and therapy management in 27 patients","volume":"18","author":"Ellenbogen","year":"2020","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Imamura, S., Oda, Y., Fukumoto, T., Mizuno, M., Suzuki, M., Washio, K., Nishigori, C., and Fukunaga, A. (2024). Solar urticaria: Clinical characteristics, treatment effectiveness, long-term prognosis, and QOL status in 29 patients. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1328765"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/AC.2000.6347","article-title":"Solar urticaria: A report on 57 cases","volume":"11","author":"Monfrecola","year":"2000","journal-title":"Am. J. Contact Dermat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/1346-8138.15234","article-title":"Characteristics and clinical significance of augmentation spectra in solar urticaria","volume":"47","author":"Uetsu","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/bjd.16325","article-title":"Paediatric solar urticaria: A case series","volume":"178","author":"Fityan","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_21","first-page":"146","article-title":"Analysis of solar urticaria in Thai patients","volume":"34","author":"Wongpraparut","year":"2016","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0781.2004.00083.x","article-title":"Solar urticaria in Singapore: An uncommon photodermatosis seen in a tertiary dermatology center over a 10-year period","volume":"20","author":"Chong","year":"2004","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000248017","article-title":"Solar urticaria in the visible spectrum successfully treated with astemizole","volume":"180","author":"Monfrecola","year":"1990","journal-title":"Dermatologica"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1365-2133.2008.08543.x","article-title":"Antihistamine combination treatment for solar urticaria","volume":"158","author":"Grundmann","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archderm.139.9.1149","article-title":"Characteristics and prognosis of idiopathic solar urticaria: A cohort of 87 cases","volume":"139","author":"Beattie","year":"2003","journal-title":"Arch. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0190-9622(93)70160-U","article-title":"Fixed solar urticaria","volume":"29","author":"Reinauer","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1111\/ced.13960","article-title":"Real-life experience in the treatment of solar urticaria: Retrospective cohort study","volume":"44","author":"Snast","year":"2019","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/phpp.12447","article-title":"Successful treatment of solar urticaria with UVA1 hardening in three patients","volume":"35","author":"Lyons","year":"2019","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ad.2018.06.005","article-title":"Induction of Light Tolerance Using Narrowband UV-B in Solar Urticaria","volume":"109","author":"Chicharro","year":"2018","journal-title":"Actas Dermosifiliogr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaad.2019.05.070","article-title":"Clinical response and long-term follow-up of 20 patients with refractory solar urticaria under treatment with omalizumab","volume":"88","author":"Podlipnik","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/phpp.12271","article-title":"Visible light-induced solar urticaria is improved by omalizumab","volume":"32","author":"Moncourier","year":"2016","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.medcli.2018.01.003","article-title":"Effectiveness in the treatment of solar urticaria with omalizumab: Report of 7 cases","volume":"151","year":"2018","journal-title":"Med. Clin."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaad.2010.05.040","article-title":"Solar urticaria treated with intravenous immunoglobulins","volume":"65","author":"Adamski","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2340\/00015555-2140","article-title":"No major effect of cyclosporin A in patients with severe solar urticaria: A french retrospective case series","volume":"95","author":"Hurabielle","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.ad.2016.08.011","article-title":"Response to Omalizumab in Solar Urticaria: Report of 3 Cases","volume":"108","author":"Chicharro","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000247734","article-title":"Plasmapheresis in solar urticaria","volume":"182","author":"Leenutaphong","year":"1991","journal-title":"Dermatologica"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2133.1982.tb04561.x","article-title":"Solar urticaria: Treatment with PUVA and mediator inhibitors","volume":"106","author":"Parrish","year":"1982","journal-title":"Br. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archderm.144.6.765","article-title":"Synergistic effect of broad-spectrum sunscreens and antihistamines in the control of idiopathic solar urticaria","volume":"144","author":"Faurschou","year":"2008","journal-title":"Arch. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000018400","article-title":"Cetirizine for solar urticaria in the visible spectrum","volume":"200","author":"Monfrecola","year":"2000","journal-title":"Dermatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jaad.2011.01.030","article-title":"Narrowband ultraviolet B phototherapy is a suitable treatment option for solar urticaria","volume":"67","author":"Zane","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0190-9622(84)80037-7","article-title":"Ultraviolet A phototherapy in the prophylaxis of solar urticaria","volume":"10","author":"Bernhard","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2133.1984.tb04639.x","article-title":"Studies on the mechanism of clinical tolerance in solar urticaria","volume":"110","author":"Keahey","year":"1984","journal-title":"Br. J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaad.2015.11.021","article-title":"Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study","volume":"74","author":"Aubin","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jaad.2014.07.023","article-title":"Severe and refractory solar urticaria treated with intravenous immunoglobulins: A phase II multicenter study","volume":"71","author":"Aubin","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_45","first-page":"85","article-title":"Oral polypodium leucotomos extract photoprotective activity in 57 patients with idiopathic photodermatoses","volume":"146","author":"Caccialanza","year":"2011","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000250495","article-title":"Assessing the treatment of solar urticaria. The dose-response as a quantifying approach","volume":"160","author":"Michell","year":"1980","journal-title":"Dermatologica"},{"key":"ref_47","first-page":"62","article-title":"A comparison of cetirizine and terfenadine in the management of solar urticaria","volume":"8","author":"Bilsland","year":"1991","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ad.2023.04.044","article-title":"Solar Urticaria and Omalizumab: A Retrospective Case-Control Study and Follow-Up","volume":"115","year":"2024","journal-title":"Actas Dermosifiliogr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"adv25576","DOI":"10.2340\/actadv.v104.25576","article-title":"Solar Urticaria: An Ambispective Study in a Long-term Follow-up Cohort with Emphasis on Therapeutic Predictors and Outcomes","volume":"104","author":"Ciudad","year":"2024","journal-title":"Acta Derm. Venereol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaad.2011.04.004","article-title":"The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: A 30-year prospective study","volume":"66","author":"Stern","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1067\/mjd.2001.114576","article-title":"The risk of melanoma in association with long-term exposure to PUVA","volume":"44","author":"Stern","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/j.jaip.2023.01.052","article-title":"Successful ligelizumab treatment of severe refractory solar urticaria","volume":"11","author":"Hershkovitz","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5736\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:26:49Z","timestamp":1760034409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":52,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14165736"],"URL":"https:\/\/doi.org\/10.3390\/jcm14165736","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}